Medication

In this Feb. 16, 2017 file photo, surgeons perform a non-emergency angioplasty at Mount Sinai Hospital in New York. Through a blood vessel in the groin, a tube is guided to a blockage in the heart. A tiny balloon is then inflated to flatten the clog, and a mesh tube called a stent is inserted to prop the artery open. According to a federally funded study released on Saturday, Nov. 16, 2019, people with severe but stable heart disease from clogged arteries may have less chest pain if they get a procedure to improve blood flow rather than just giving medicines a chance to help, but it won't cut their risk of having a heart attack or dying over the following few years. (AP Photo/Mark Lennihan)
November 16, 2019 - 2:02 pm
PHILADELPHIA (AP) — People with severe but stable heart disease from clogged arteries may have less chest pain if they get a procedure to improve blood flow rather than just giving medicines a chance to help, but it won't cut their risk of having a heart attack or dying over the following few years...
Read More
This undated image provided by Novartis shows bottles of Novartis’s Adakveo. U.S. regulators have approved the new sickle cell disease medicine that can prevent extremely painful, dangerous “crises” in which misshapen blood cells clump together, reducing blood and oxygen flow. (Novartis via AP)
November 15, 2019 - 4:35 pm
U.S. regulators on Friday approved a new medicine that can help reduce extremely painful sickle cell disease flare-ups. The Food and Drug Administration approved Novartis AG’s Adakveo for patients 16 and older. The monthly infusion, which halves occurrences of sickle cell pain episodes, will carry...
Read More
M. Russell Ballard, a senior leader of The Church of Jesus Christ of Latter-day Saints and acting president of the Quorum of Twelve Apostles, speaks during an interview, Friday, Nov. 15, 2019, at the Associated Press headquarters in New York. (AP Photo/Emily Leshner)
November 15, 2019 - 3:59 pm
NEW YORK (AP) — A high-ranking leader with The Church of Jesus Christ of Latter-day Saints said Friday the church severed its century-long tie with the Boy Scouts of America because the organization made changes that pushed it away from the church. “The reality there is we didn’t really leave them...
Read More
This undated image provided by Novartis shows bottles of Novartis’s Adakveo. U.S. regulators have approved the new sickle cell disease medicine that can prevent extremely painful, dangerous “crises” in which misshapen blood cells clump together, reducing blood and oxygen flow. (Novartis via AP)
November 15, 2019 - 3:48 pm
U.S. regulators on Friday approved a new medicine that can prevent some extremely painful sickle cell disease flare-ups. The Food and Drug Administration approved Novartis AG’s Adakveo for patients 16 and older. The monthly infusion, which halves occurrences of sickle cell pain episodes, will carry...
Read More
M. Russell Ballard, a senior leader of The Church of Jesus Christ of Latter-day Saints and acting president of the Quorum of Twelve Apostles, speaks during an interview, Friday, Nov. 15, 2019, at the Associated Press headquarters in New York. (AP Photo/Emily Leshner)
November 15, 2019 - 2:34 pm
NEW YORK (AP) — A high-ranking leader with The Church of Jesus Christ of Latter-day Saints said Friday the church severed its century-long tie with the Boy Scouts of America because the organization made changes that pushed it away from the church. “The reality there is we didn’t really leave them...
Read More
FILE - This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Thursday, Nov. 14, 2019, government health advisers recommended broader use of the prescription-strength fish oil drug to prevent heart attack, stroke and other life-threatening health problems. (Amarin via AP)
November 14, 2019 - 4:54 pm
WASHINGTON (AP) — U.S. health advisers are recommending broader use of a prescription-strength fish oil drug to help prevent heart problems. The non-binding recommendation paves the way for the Food and Drug Administration to expand the drug’s approval. That broader use could translate into...
Read More
This 1971 microscope image made available by the Centers for Disease Control and Prevention shows Neisseria gonorrhoeae bacteria, which causes the sexually transmitted disease gonorrhea. In a report released Wednesday, Nov. 13, 2019, the Centers for Disease Control and Prevention estimated about 36,000 Americans died from drug-resistant infections in 2017 _ down about 18% from an estimated 44,000 in 2013. Though deaths may be going down, non-fatal infections increased nationally from 2013 to 2017, from 2.6 million to 2.8 million. Dramatic increases in drug-resistant gonorrhea, urinary tract infections, and group A strep were largely to blame. (CDC via AP)
November 13, 2019 - 2:07 pm
NEW YORK (AP) — Drug-resistant “superbug” infections have been called a developing nightmare that could set medicine back a century, making conquered germs once again untreatable. So there’s some surprising news in a report released Wednesday: U.S. superbug deaths appear to be going down. About 36,...
Read More
FILE - In this July 1, 1960 file photo, a chemist works in laboratory in Cambridge, Mass. For decades, scientists have used "statistical significance" to estimate whether their results are reliable or just flukes. It’s long been criticized, but 2019 has brought two high-profile calls to get rid of it entirely. (AP Photo/Peter J. Carroll)
November 12, 2019 - 12:25 pm
NEW YORK (AP) — Earlier this fall Dr. Scott Solomon presented the results of a huge heart drug study to an audience of fellow cardiologists in Paris. The results Solomon was describing looked promising: Patients who took the medication had a lower rate of hospitalization and death than patients on...
Read More
FILE - This June 14, 2011, file photo, shows the pills of the drug Lipitor in Willingboro, N.J. Researchers examined records of people taking cholesterol-lowering medicine between 2005 and 2016, a few years after a big change in treatment guidelines. They found encouraging drops, suggesting the change may be paying off. (AP Photo/Matt Rourke, File)
November 11, 2019 - 2:04 pm
WASHINGTON (AP) — Some good health news: Americans' cholesterol levels are dropping, and more people at especially high risk are getting treatment. Researchers say Monday's report suggests a controversial change in recommendations for cholesterol treatment may be starting to pay off. "It is very...
Read More
FILE - In this Nov. 8, 2018, file photo, the U.S. Medicare Handbook is photographed, in Washington. A new study finds that more than half of seriously ill Medicare enrollees _ 53% _ struggle to pay their medical bills. Prescription drugs are the leading problem. The researchers who wrote Monday’s report in the journal Health Affairs were surprised by their findings, since Medicare is considered relatively good coverage. (AP Photo/Pablo Martinez Monsivais, File)
November 08, 2019 - 5:48 pm
WASHINGTON (AP) — Medicare's "Part B" premium for outpatient care will rise by nearly 7% to $144.60 a month next year, officials said Friday. They blamed rising spending on medications. The $9.10 monthly increase follows a smaller $1.50 rise this year. It comes after Social Security announced a...
Read More

Pages